PUBBLICAZIONE/PUBLICATION
Permanent URI for this communityhttps://gendermore.unimore.it/handle/123456789/1575
Browse
2 results
Search Results
Item type:Publication, Exploring gender disparities in first authorship in anatomy during last two decades Open PDF(Springer Science and Business Media LLC, 2025-02-21) ;Singal, AnjaliGoyal, SwatiAbstract Purpose In scientific literature, authorship serves as a vital form of symbolic capital, with first authorship especially signifying active research involvement. This study examines the presence and magnitude of the gender gap in Anatomy research authorship and tracks its progression over the past twenty years in five esteemed journals. To our knowledge, this is the first study to explore the trend of female first authorship within the subject. Methods PubMed search for all the published articles in five reputed Anatomical journals (2004–2023) was performed to get the bibliographic details of each article. Rentrez package was used to retrieve full name and affiliation. The first authors from the Department of Anatomy, Morphology, Embryology and Histology were included. Gender of the first author was assessed using Namsor API. The proportions of female first authors were presented as percentage stratified year-wise and geographically. A Mann-Kendall trend test statistics was applied to observe the significance of trends. Results One third of publications were by female first authors in Anatomy in last two decades. Continent wise, Africa and North America had the highest and lowest female representation. Participation of female as first authors was relatively consistent across journals (31.6 -34.8%). Though trend for female first authors increased in 2023 (38.8%) as compare to in 2004 (28.9%), however Mann-Kendall trend test statistics indicate no significant increase in yearly trend (p = 0.552) during last twenty years. Conclusions Globally males continue to dominate the prestigious first authorship in Anatomy except in India and Italy. Future research is needed to fully understand the obstacles preventing female representation as first authors in different geographic areas in this discipline.Item type:Publication, Characteristics of Heart Failure Trials Associated With Under-Representation of Women as Lead Authors Open PDF(2020) ;Whitelaw, Sera ;Thabane, Lehana ;Mamas, Mamas A. ;Reza, NosheenBreathett, KhadijahBACKGROUND: Clinical trials change practice in cardiology, and leading them requires research training, mentorship, sponsorship, and networking. Women report challenges in obtaining these opportunities. OBJECTIVES: The purpose of this review was to evaluate temporal trends in representation of women as authors in heart failure (HF) randomized controlled trials (RCTs) published in high-impact medical journals and explore RCT characteristics associated with women as lead authors. METHODS: We searched MEDLINE, EMBASE, and CINAHL for HF RCTs published in journals with an impact factor ≥10 between January 1, 2000, and May 7, 2019. We assessed temporal trends in the gender distribution of authors, and used multivariable logistic regression to determine characteristics associated with women as lead authors. RESULTS: We identified 10,596 unique articles, of which 403 RCTs met inclusion criteria. Women represented 15.6% (95% confidence interval [CI]: 12.2% to 19.6%), 12.9% (95% CI: 9.8% to 16.6%), and 11.4% (95% CI: 8.5% to 14.9%) of lead, senior, and corresponding authors, respectively. The proportion of women authors has not changed over time. Women had lower odds of lead authorship in RCTs that were multicenter (odds ratio [OR]: 0.58; 95% CI: 0.18 to 0.96; p = 0.037), were coordinated in North America (OR: 0.21; 95% CI: 0.08 to 0.70; p = 0.011) or Europe (OR: 0.33; 95% CI: 0.09 to 0.91; p = 0.039), tested drug interventions (OR: 0.42; 95% CI: 0.16 to 0.97; p = 0.043), or had men as the senior author (OR: 0.50; 95% CI: 0.21 to 0.93; p = 0.043). CONCLUSIONS: Women are under-represented as authors of HF RCTs, with no change in temporal trends. Women had lower odds of lead authorship in RCTs that were multicenter, were coordinated in North America or Europe, tested drug interventions, or had men as senior authors.